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Abstract
Ultraviolet light in the UVC range is a commonly used disinfectant to control viruses in clinical settings and water treat-
ment. However, it is currently unknown whether human viral pathogens may develop resistance to such stressor. Here, we
investigate the adaptation of an enteric pathogen, human echovirus 11, to disinfection by UVC, and characterized the
underlying phenotypic and genotypic changes. Repeated exposure to UVC lead to a reduction in the UVC inactivation rate of
approximately 15 per cent compared to that of the wild-type and the control populations. Time-series next-generation
sequencing data revealed that this adaptation to UVC was accompanied by a decrease in the virus mutation rate. The inacti-
vation efficiency of UVC was additionally compromised by a shift from first-order to biphasic inactivation kinetics, a form of
‘viral persistence’ present in the UVC resistant and control populations. Importantly, populations with biphasic inactivation
kinetics also exhibited resistance to ribavirin, an antiviral drug that, as UVC, interferes with the viral replication. Overall,
the ability of echovirus 11 to adapt to UVC is limited, but it may have relevant consequences for disinfection in clinical set-
tings and water treatment plants.
Key words: virus; experimental evolution; ultraviolet radiation; disinfection; ribavirin; resistance.
1. Introduction
Human-hosted viruses, especially those with single-stranded
RNA genomes, may exhibit high mutation rates, short genera-
tion times, and large census population sizes compared to other
organisms. These traits contribute to a remarkable genetic and
functional diversity and allow viruses to adapt to various chal-
lenges, such as environmental stressors or antiviral drugs
(Duffy et al. 2008; Holmes 2009; Irwin et al. 2016). In recent years,
the resistance of major viral pathogens such as influenza
viruses or HIV to antiviral drugs has become one of the most
serious concerns for public health (Hue´ et al. 2009; Kuritzkes
2011; Foll et al. 2014; Hurt 2014).
Disinfectants such as chemical oxidants (e.g. chlorine) or
UVC radiation are of major importance to controlling the dis-
semination and transmission of viral pathogens via food, water
or in clinical settings. Yet, the long-term effects of disinfectant
use on the evolution of virus populations have not been
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investigated and may counteract the intended positive effects
of disinfection. To date, only few studies explored the potential
emergence of viral resistance to disinfectants. Notably, viruses
isolated from chlorinated drinking water or sewage have been
found to be less susceptible to disinfection than their corre-
sponding laboratory strains (Shaffer et al. 1980; Payment et al.
1985). In laboratory studies, repeated exposure of poliovirus and
the bacteriophage F116 to free chlorine led to the development
of resistance (Bates et al. 1978; Maillard et al. 1998). Similarly,
MS2 bacteriophages and human echovirus 11 (E11) became
increasingly resistant to disinfection by chlorine dioxide upon
repeated exposure in vitro (Zhong et al. 2016, 2017).
Combined, these studies suggest that human-hosted viruses
with resistance to disinfection can emerge and indeed be
sampled in the environment. However, infective viruses are not
routinely monitored after disinfection because the costs and
time demands associated with such a practice are currently pro-
hibitive. As a result, there are no available data on the circula-
tion of disinfection resistant viruses, and no information exists
regarding their genetic composition. In order to investigate dis-
infection resistance mechanisms and the underlying genetic
changes, we can therefore not rely on previous observations of
genetic adaptation, but must instead produce resistant viruses
and monitor the associated changes in vitro.
The UVC portion (100–280 nm) of UV radiation is one of the
most frequently used physical disinfectants. Its most common
applications include clinical sterilization of tools and surfaces
in healthcare facilities, as well as drinking and wastewater
treatment (Moeller et al. 2010). In water treatment, UVC owes its
recent popularity to its efficiency against protozoan oocysts that
are naturally resistant to chemical disinfection by chlorine
(Hijnen et al. 2006), and to a lack of toxic disinfection byprod-
ucts. Besides engineered applications, genome damage medi-
ated by UV light in the solar spectrum largely contributes to the
natural inactivation of both autochthonous and pathogenic
microorganisms in aquatic ecosystems (Carratala` et al. 2013;
Mojica and Brussaard 2014). The antimicrobial activity of UVC
arises from the random formation of photoproducts such as
cyclobutane pyrimidine dimers (CPDs) in DNA and RNA chains
upon exposure to radiation. These photoproducts act in two
ways: they can block viral replication by interfering with the
polymerase and can promote the random introduction of dele-
terious mutations across the entire viral genomes (Ikehata and
Ono 2011). Thus, the emergence of resistant viruses to UVC may
require a greater extent of genetic and phenotypic changes as
compared to the mutations needed for the development of
resistance against drugs or other stressors with specific genetic
targets (Bank et al. 2016).
We here investigate the response of virus populations to
continued exposure to UVC radiation using human E11, an
enteric human pathogen. E11 is a representative of the
Enterovirus genus of the Picornaviridae family, which also
includes Coxsackievirus, Rhinovirus and Poliovirus. Enteroviruses
are small (20–32 nm diameter), single-stranded (ss) RNA icosa-
hedral viruses. Host entry is usually via the gastrointestinal
tract, and thus the major mode of transmission is fecal-oral
contact. Infection is associated with a wide variety of clinical
symptoms, from asymptomatic to severe, which include polio-
myelitis, common respiratory symptoms, and gastrointestinal
disease as well as other non-specific symptoms (Tapparel et al.
2013). Since enterovirus virions are excreted by their hosts at
high concentrations (up to 1010 viruses/g of feces) over long peri-
ods of time, their presence in raw wastewater is of concern
(Gantzer et al. 1998; Sedmak et al. 2003; Lodder and de Roda
Husman 2005; Okoh et al. 2010). Some studies have shown that
enteroviruses can withstand wastewater treatments.
Consequently, they are usually detectable in drinking water
sources and surface waters that receive wastewater effluents
(Shaffer et al. 1980; Lodder et al. 2010; Simmons and Xagoraraki
2011; Zhou et al. 2015), where they can persist for extended time
periods and present a public health risk (Rzezutka and Cook
2004; Carter 2005).
Human enteroviruses are readily cultivated and easily
handled in laboratory conditions, and, consequently, many
recent studies of experimental evolution employ these viruses
as a model. These studies have shown that human enterovi-
ruses easily adapt to stressors, such as antiviral drugs targeting
viral replication (e.g. ribavirin and guanidine hydrochloride),
harmful environmental conditions (e.g. high temperatures), or
even disinfectants (e.g. chlorine) (Bates et al. 1978; Shiomi et al.
2004; Sadeghipour et al. 2012, 2013). Furthermore, due to the
typically high mutation rates of these viruses and to their high
recombination rates, novel enterovirus genotypes emerge or re-
emerge on a regular basis (Palacios and Oberste 2005; Modlin
2007).
The goal of the present study was to assess whether UVC
resistant enteroviruses emerge under directed experimental
adaptation and to characterize these populations with respect
to both genotype and phenotype. To this end, we have com-
bined experimental evolution, disinfection experiments and
population genetics analyses to illuminate the mechanisms of
virus adaptation to an infrequently studied causal agent (UVC
radiation).
2. Materials and methods
2.1 Virus preparation and quantification
Human E11 stocks (Gregory strain, ATCCVR VR737TM) were pro-
duced by infecting sub-confluent monolayers of Buffalo green
monkey kidney (BGMK) cells. The cells were maintained at 37 C
in 5 per cent CO2 with modified Eagle medium (MEM) (Gibco,
Frederick, MD), supplemented with 1 per cent Penicillin-
Streptomycin (Gibco, Frederick, MD) and 10 per cent (growth
medium) or 2 per cent (maintenance medium) heat-inactivated
fetal bovine serum (FBS; Gibco, Frederick, MD). The viruses were
released from infected cells by freezing and thawing the culture
flasks three times. To eliminate cell debris, the suspensions
were centrifuged at 3,500 rpm for 5 minutes. To quantify the
virus samples, we used a most probable number (MPN) infectiv-
ity assay. Briefly, BGMK cells were grown to 95 per cent conflu-
ence in flat-bottom ninety-six-well plates (Greiner CELLSTARVR
ninety-six-well plates; Sigma Aldrich). Then, virus samples
were diluted over a tenfold dilution series in MEM supple-
mented with 2 per cent FBS. The medium in each well was dis-
carded and replaced with 150 ml of a diluted virus sample.
Infected plates were then incubated for 5 days, after which
inverted microscopy was used to differentiate infected from
non-infected wells. E11 concentrations in the samples were
then determined as the MPN of cytopathic units per milliliter
(MPNCU/ml). The resulting stock solutions (109 MPNCU/ml)
were stored at 4 C until use.
2.2 Directed experimental evolution passages
Prior to the UVC-adaptation, an E11 population (hereafter
referred to as WT) was adapted to cell culturing in BGMK cells
by conducting three passages in the presence of MEM
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supplemented with 2 per cent FBS and Ribavirin (400mM). The
resulting population (henceforth named WT Ribþ) served as the
starting population for the following experimental evolution
passages. Ribavirin was used here to increase the level of
genetic diversity of the prototype laboratory strain used in the
study, as higher diversity promotes adaptation (Vignuzzi et al.
2006). While the UVC inactivation kinetics of the WT and the
WT Ribþwere equivalent (P¼ 0.79, data not shown), the WT
Ribþpopulation grew to higher titers in BGMK cells as com-
pared to the original WT (P< 0.05, data not shown), confirming
that the WT Ribþpopulation is indeed better adapted to grow in
the cell culture system used herein.
The cell culture pre-adapted WT populations (WT Ribþ) were
experimentally evolved in BGMK cells over twenty cycles. Each
evolution passage included two steps: first the virus populations
were exposed to UVC radiation, and then the survivors were
regrown in BGMK cells for 3 days to increase the population size
(Fig. 1). After regrowth, the viruses were released as detailed
above and the experiment proceeded with a new round of UVC
inactivation and regrowth. UVC radiation was produced from an
18 W low-pressure UVC lamp (model TUV T8; Philips), which
emitted 253.7 nm light as quasi-collimated beam. The fluence
rate was determined by actinometry (Rahn 1997) and corre-
sponded to 10.43 mJ/cm2 min. The UVC fluence was assigned to
achieve a 4 log10 reduction in infective virus titers, simulating a
commonly used target threshold for virus inactivation in water
treatment. Up to Passage 14, this fluence corresponded to 31.28
mJ/cm2. At Passage 15, due to the emergence of resistant viruses,
the UVC fluence was increased to 52.14 mJ/cm2 until the end of
the experiment. The 4 log10 reduction in virus titer resulted in a
low multiplicity of infection (MOI) for regrowth of approximately
0.0001.
The typical replication time of enteroviruses is known to
range between 5 and 10 hours (Knipe and Howley 2013). In the
experimental evolution approach used herein, the regrowth
phase in each passage lasted 72 hours, which corresponds to a
maximum of 14.4 generations per passage. Assuming three to
ten generations per passage, the twenty experimental evolution
passages conducted thus corresponded to approximately 60–
200 viral generations.
Control experiments with non-exposed populations were
conducted in parallel, in reactors protected from UVC radiation
with a cover of aluminum foil. Instead of inactivation by UVC,
the concentration of these viruses was diluted with phosphate
buffer by 4 log10 before being regrown, purified, and re-diluted.
Hereafter, the final evolved populations (at Passage 20) will be
referred to with the abbreviations E01 (exposed, Replicate 1) or
NE01 (non-exposed, Replicate 1). Three biological replicates for
both exposed (E02, E03, and E04) and non-exposed (NE02, NE03,
and NE04) treatment groups were conducted using the same
WT Ribþas a founder population, in order to investigate the
repeatability of our experimental evolution assays using one
specific lineage.
2.3 UVC inactivation experiments
To determine the degree of UVC adaptation in the previously
UVC exposed and control populations as compared to the WT
Ribþ, inactivation experiments were conducted every five pas-
sages. To this end, virus aliquots were spiked into 20 ml black
glass beakers containing 2 ml of virus dilution buffer (VDB;
5 mM Na2HPO4, 10 mM NaCl, 1 mM NaOH; pH 7.2) to yield a con-
centration of approximately 107 MPNCU/mL, and were exposed
to UVC light. The UV absorbance at 254 nm was measured for all
samples (UV-2550; Shimadzu) to verify that samples did not dif-
fer in their extent of light screening. Aliquots were withdrawn
periodically over 11 minutes, corresponding to a fluence of
114.70 mJ/cm2. The infective viruses in each sample were
enumerated on the same day by MPN infectivity assays as
detailed above. Inactivation rate constants k were determined
Figure 1. Experimental set-up. Echovirus 11 was propagated infecting Buffalo green monkey kidney (BGMK) cells in monolayers. The viruses were adapted to cell cul-
ture for three passages in the presence of ribavirin and then serially passaged after exposure to UVC or after an equivalent dilution between cell culture infections. The
multiplicity of infection (MOI) in the experimental evolution passages was 0.0001.
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by least-square fit of the data to a first-order model according to
the following equation:
ln
N
N0
 
¼ kIt
where N0 and N are the infective virus concentrations (MPNCU/
mL) at times 0 and t, I is the fluence rate (mJ/cm2  min), and t is
the time (min).
2.4 Replicative fitness assays
To characterize the replicative fitness of the evolved popula-
tions, we compared the growth kinetics of E01 to that of the WT
Ribþ in BGMK cells. Specifically, sub-confluent monolayers
were infected at an MOI of 0.001 and incubated at 37 C and 5
per cent of CO2. Aliquots of the culturing media were collected
periodically over 96 hours post infection and the increase in
virus titer was quantified by MPN assay.
2.5 Competition assays
We conducted competition experiments to determine whether
under our experimental conditions the evolved populations
could outcompete the WT Ribþwhen co-cultured in BGMK cells.
Specifically, clonal virus populations were established from the
WT Ribþand E01 populations by scission of isolated plaques
using two successive plaque assays. The isolated plaques were
transferred to 100 ll of VDB and were incubated overnight at
4 C. Then, the liquid phase was transferred to a new tube and
quantified as described above. Finally, the populations were
mixed at 1:1 and 1:0.01 ratio of WT Ribþ:E01. The mixtures were
then spiked into cell culture flasks with sub-confluent BGMK
monolayers and were passaged four times. Samples were
retained at passages 0, 2, and 4, and a fragment in the 3Dpol
region was then sequenced using Sanger sequencing as
described below. In the sequenced fragment, the evolved
viruses contain a known mutation (T347A) while the WT
Ribþviruses do not. This mutation thus allowed us to identify
the dominant virus population after passaging.
2.6 Resistance to ribavirin
To determine if the evolved viruses exhibited cross-resistance
to other agents that inflict random mutagenesis across viral
genomes, we exposed different viral populations to an antiviral
drug, ribavirin, and compared the viral titer in the stationary
growth phase (48–72 hours post infection). This assay was con-
ducted for populations WT, WT Ribþ, E01, and NE01. In addi-
tion, several Rib- control populations (WT Rib-, E01, and NE01)
were included in these analyses to ensure that resistance to rib-
avirin was not a result of the initial exposure the founder popu-
lation to this drug. Rib-populations were obtained by passaging
the WT three times in BGMK cells in the presence of MEM sup-
plemented with 2 per cent of FBS and in the absence of ribavirin,
and later evolved experimentally as previously detailed for the
Ribþ lineage.
BGMK cells were seeded in six-well plates, and sub-
confluent monolayers were incubated with MEM 2 per cent sup-
plemented with 1.6 mM ribavirin for 30 minutes before adding
the viral suspensions at an initial concentration of approxi-
mately 103 MPNCU/ml. After 48 hours of incubation, the plates
were subjected to three freeze–thaw cycles, and the samples
were collected and centrifuged at 3,500  g for 5 minutes to
eliminate cell debris. The virus-containing supernatant was
then collected, and the samples were quantified by MPN assay.
2.7 Sanger sequencing
Nucleic acid extractions were completed using the PureLinkTM
Viral RNA/DNA kit (Invitrogen) following manufacturer’s
instructions. The extracted RNA was reverse transcribed and
amplified with a OneStep RT-PCR Kit (Qiagen) in a Trio thermal
cycler (Biometra) using twenty-eight sets of primers, which
cover almost the entire genome of E11, and were designed
based on the reference strain (NCBI accession number X80059.1)
(Supplementary Table S1). The obtained Polymerase chain reac-
tion (PCR) amplicons were then purified using the MSB Spin
PCRapace Kit (Stratec). The sequencing PCR reactions were con-
ducted for twenty cycles as follows: 96 C for 10 seconds, 50 C
for 10 seconds, 60 C for 4 minutes with a final hold at 12 C
using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems). Lastly, the nucleic acids were sequenced in an ABI
3130x Genetic Analyzer (Applied Biosystems).
2.8 Amplicon-based deep sequencing
Amplicon-based deep sequencing was conducted for the WT
Ribþpopulation, for Passages 5, 7, 10, 15, and 18 of E01 and
NE01, and for Passage 20 of all biological replicates of E and NE.
Sequencing libraries of 100 bp double-stranded cDNA were built
using the TruSeq Stranded mRNA Library Prep kit (Illumina)
from 300 bp PCR amplicons obtained and purified as described
in the previous section. The PCR amplicons were pooled
together to obtain 100 ng of nucleic acids. The concentration of
nucleic acids and quality of the obtained libraries were deter-
mined by Nanodrop 2000 (Thermo Fisher Scientific Inc.) and
Fragment analyzerTM (Advanced Analytical). Up to six inde-
pendent libraries were barcoded and pooled for sequencing
using the Illumina HiSeq 2500 platform at the Lausanne
Genomics Technologies Core Facility. Single-read reads of
100 bp were generated, trimmed, and cleaned for further analy-
ses in the Bioinformatics and Biostatistics Core Facility at EPFL.
The reads were mapped to the reference strain of E11 (NCBI
accession number X80059.1). The sequencing error threshold
was experimentally determined as described elsewhere and
corresponded to 1 per cent.
2.9 Accession numbers
Genome sequence obtained by next-generation sequencing
(NGS) have been deposited in NCBI’s BioSample database with
the accession numbers SAMN07654485 to SAMN07654503.
2.10 Effective population size analyses
Effective population size (Ne) can be estimated by the amount of
fluctuation in allele frequencies through time (Jorde and Ryman
2007). The unbiased estimator Fs0 of Ne is given by Jorde and
Ryman (2007) as:
F0s ¼
1
ti
Fs ½1  12~n  2~n
ð1 þ Fs4 Þ½1  1nmþ1
with Fs ¼ ðfm  fmþ1Þ
2
fi ð1  fiÞ
where fm and fmþ1 are the minor allele frequencies at two con-
secutive sampling time points (m and mþ 1), fi¼ (fmþ fmþ1)/2,
and ~n is the harmonic mean of the sample sizes nm and nmþ1
at two consecutive sampling time points. From the
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pool-sequenced time-serial samples, only single nucleotide
polymorphisms (SNPs) above our ascertainment frequency of
0.5 per cent in one of the sampling time points and with cover-
age depth of at least 100 were considered. For each site in the
genome, a major allele was defined as the nucleotide with the
highest frequency at the first sampling time point, and a minor
allele as the SNP with the highest frequency at the last sampling
time point. The minor allele frequencies from populations NE01
and E01 were collated into input files for the software WFABC
(Foll et al. 2014, 2015), which was used to calculate the Ne of
each population. The following command line was used to exe-
cute the estimation of Ne from these input allele frequency
trajectories:
./wfabc_1 FILE –min_freq 0.005 –ploidy 1
We assumed 10 viral generations per passage and a sample
size of 100 per sampling time point. The posterior distribution
of Ne was drawn from 10,000 samples generated using a
Bayesian bootstrap approach (Rubin 1981; Hall 1985). The results
for whole-genome estimates of Ne for each population are given
in Supplementary Fig. S3. Furthermore, the time-serial Ne of
NE01 and E01 populations was calculated with WFABC software
by considering allele frequency trajectories between consecu-
tive sampling time points (Fig. 5). In addition, the protein-
specific Ne for each protein in NE01 and E01 populations was
calculated using the same method (Supplementary Fig. S4).
2.11 Ratio of non-synonymous to synonymous segregat-
ing sites by protein
The ratio of non-synonymous to synonymous segregating sites
(pN=pS) was calculated for each protein-coding gene. First, the
WT Ribþwas used as the reference sequence to define segregat-
ing SNPs of each protein-coding gene, which were defined as
those with minor alleles segregating at or above 1 per cent (the
sequencing error threshold) at the last sampling time point.
Secondly, the expected number of non-synonymous and synon-
ymous sites in the reference sequence was calculated for any
particular codon by denoting fi as the fraction of non-synony-
mous segregating sites at the ith codon position (i¼ 1, 2, 3). The
number of expected non-synonymous (N) and synonymous (S)
sites for a codon in the reference sequence (Morelli et al. 2013),
was calculated as:
N ¼
X3
i¼1
fi and S ¼ ð3 NÞ
Lastly, the segregating SNPs in each protein-coding gene of
the NE01 and E01 populations were categorized as either non-
synonymous or synonymous mutations using Bioconductor
software (Version 3.4), and compared to the expected number of
non-synonymous/synonymous sites in the reference sequence
respectively. The ratio of non-synonymous (Nsample) to synony-
mous (Ssample) segregating SNPs in the NE01 and E01 samples
per expected non-synonymous (N) to synonymous (S) segregat-
ing sites in the reference was summarized for each protein in
Table 1, where the ratio (pN=pS) is given as:
pN
pS
¼ Nsample=N
Ssample=S
2.12 Calculation of the mutation rate from time-series
NGS data
In this mutation-accumulation experiment, identical lines of
E11 were subjected to a series of consistent but extreme
Table 1. Heatmap of the frequency of the mutations detected by NGS in the NE and E populations after twenty experimental evolution passages.
Protein NT AA WT E20 NE20
Replicate 1 Replicate 2 Replicate 3 Replicate 4 Replicate 1 Replicate 2 Replicate 3 Replicate 4
VP4 A849T Y33F 0 100 0 0 0 0 0 0 0
VP2 G1373C G139R 39 100 100 100 100 100 100 100 100
VP3 A2283G / 1 0 100 100 100 99 75 99 100
VP1 C2842T / 3 99 0 0 0 1 0 0 0
G3164A C236I 0 0 70 0 75 19 81 27 40
A3170G M238V 6 100 99 99 100 100 98 100 100
A3233G K259Q 6 99 99 99 100 99 98 99 99
2C T4200C V40A 0 100 0 0 0 45 2 2 1
G4262A A61T 1 1 100 99 100 95 90 51 100
C4263T / 1 0 100 100 100 4 88 38 98
A4552G / 4 100 100 100 100 96 75 99 100
T4990C / 1 100 0 0 0 1 0 0 0
3A G5170A / 0 100 0 0 0 0 0 0 0
3C A5893T / 4 100 100 100 100 96 91 61 100
3D C6061T / 5 100 100 100 100 96 91 62 100
G6409A / 22 100 100 100 100 98 91 96 100
C6931T / 0 100 0 0 0 0 0 0 0
A6989G T347A 3 99 100 99 100 99 99 99 99
NT and AA stand for the nucleotide and amino acid position, respectively. The table includes all mutations that increased from minor to major allele compared to the
starting population in at least one of the replicates. Heatmap of the frequency of the mutations detected by NGS in the NE and E populations after twenty experimental
evolution passages. Yellow and blue colours stand for lower to higher frequencies, respectively.
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population bottlenecks such that mutations accumulate under
effective neutrality (which does not apply in cases of complete
lethality; Lynch et al. 2016). The control experiments (NE01) fol-
low this scheme, while the UVC experiments (E01) also involve
the selective pressure of UV damage. We do however use the
same procedure to calculate the mutation rate in both experi-
ments. The number of new mutations was taken as the number
of newly arising mutations per generation per site between
each pair of consecutive sampling time points as shown in
Supplementary Table S2. Newly arising mutations are defined
as nucleotides that appear de novo above the error threshold at a
sampling time point. The error threshold was set at a conserva-
tive level of 1 per cent, and the protein-coding genome size
(above the coverage of 100) was calculated as 6567. Finally, 10
generations were assumed to pass between each passaging.
Using these parameters, the time-serial mutation rate was cal-
culated by dividing the number of new mutations between a
pair of passages by the time-serial effective population size. The
results for the total mutation rate are summarized in
Supplementary Table S2, and for the synonymous mutation
rate in Supplementary Table S3, where the number of synony-
mous sites in the protein-coding genome was calculated to be
1696.3.
2.13 Data analyses
All statistical analyses were conducted using the Graph Pad
Prism software (Prism 7 version 7.0a, 2016). Multiple comparison
of inactivation rate constants and resistance against ribavirin
between the WT and the evolved populations was performed by
ordinary Analysis of variance (ANOVA) tests (Dunnett’s multiple
test, with a single pool variance and a¼ 0.05).
3. Results
3.1 Phenotypic evolution of UVC-adapted populations
3.1.1 Adaptation to UVC radiation
Inactivation of the WT Ribþand all biological replicates are
shown in Fig. 2 as a function of UVC fluence. It is evident from
these data that even after twenty rounds of UVC exposure and
regrowth, UVC is still able to inactivate E11. Nevertheless, a sig-
nificant enhancement in the resistance to UVC was observed in
the UVC exposed (E) populations. This enhanced resistance to
UVC was manifested in a smaller first-order inactivation rate
constant k, which was determined from the first-order portion
of the inactivation curve up to a UVC fluence of 41.71 mJ/cm2.
Specifically, the k values associated with E01 at Passages 15 and
20 were reduced (P< 0.05) by 11 per cent (k¼ 0.24 cm2/mJ) and 15
per cent (k¼ 0.23 cm2/mJ), respectively, compared to the k value
of the WT Ribþ (k¼ 0.27 cm2/mJ). Equivalent change in k was
observed in all four biological replicates (Fig. 2) and was strictly
associated with exposure to UVC radiation; the non-exposed
populations did not exhibit a decreasing trend in k
(Supplementary Fig. S1).
Figure 3 shows the measured log inactivation for popula-
tions WT Ribþ, E01 and NE01 at the different UVC fluences
tested. At fluences of 41.71 and 62.56 mJ/cm2, the extent of inac-
tivation between E01 and WT Ribþdiffered by 0.8 and 1.4 log
units, respectively (P¼ 0.004 and P¼ 0.01), whereas no signifi-
cant difference between NE01 and WT Ribþwas observed
(P> 0.05). In summary, while the observed decrease in k is mod-
est, it results in a significant reduction in the inactivation
achieved at typical UVC fluences applied in water treatment.
3.1.2 Replicative fitness of UVC-resistant populations
In order to determine whether the increase in UVC resistance
reduced the replicative fitness of the evolved populations, the
growth of the E01 on BGMK cells was compared to that of the
WT Ribþ. If grown in independent cell cultures, the E01 popula-
tion exhibited equivalent growth kinetics as WT Ribþ (data not
shown). A different outcome was observed in competition
assays, in which the E01 populations were mixed at 1:1 and
0.01:1 ratios with the WT Ribþ, and were co-cultured on BGMK
cells over four passages. Sequencing of the regrown populations
revealed that—independent of the initial population ratio—the
evolved populations (both exposed and non-exposed) rapidly
outcompeted WT Ribþ (data not shown). Overall, these results
indicate that, under our experimental conditions, UVC resistant
viruses show no major replicative trade-offs as compared to the
founding population.
3.1.3 Emergence of biphasic kinetics, a form of ‘viral persistence’
In addition to the reduction in k, a second mechanism leading to
UVC resistance was observed. Specifically, the UVC inactivation
of the WT Ribþpopulation reached the detection limit of the
technique after being exposed to a fluence of 50 and 75 mJ/cm2,
respectively (Supplementary Fig. S1). However, as passaging
increased, we observed the onset of a tailing inactivation curve
in all control (non-exposed) and UVC-exposed populations. Due
to this tailing feature, the detection threshold increased to
Figure 2. UVC inactivation of the wild-type (WT Ribþ) and all the biological repli-
cates of the population exposed to UVC (E01 to E04) after twenty passages of
experimental adaptation. At minimum of three replicates were conducted for
each population at initial concentrations of approximately 107 MPNCU/ml.
Figure 3. Virus log inactivation obtained for the WT Ribþ, NE01 and E01 after
exposure to different UVC fluences. Asterisks indicate statistically significant
differences compared to the wild-type (WT) Ribþ. Different data points repre-
sent replicate experiments.
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100 mJ/cm2 or more for all NE and E populations (Supplementary
Fig. S1). All E and NE populations were evolved under severe and
serially repeated bottlenecks, even if the bottlenecks were due to
different processes (UVC exposure versus dilution). The emer-
gence of tailing may thus be linked to the process of frequent
regrowth from low MOI.
3.1.4 Resistance to antiviral drugs
Like UVC, some antiviral drugs, such as ribavirin, lead to ran-
dom mutagenesis during replication. Ribavirin is a mutagenic
nucleotide analog that interferes with the replication of human
enteroviruses by causing mutation accumulation in the viral
progeny (Crotty et al. 2000; Graci and Cameron 2002; Palma et al.
2008). The genetic basis of ribavirin resistance in different enter-
oviruses, such as poliovirus or enterovirus 71, has been charac-
terized in previous studies (Pfeiffer and Kirkegaard 2003;
Sadeghipour et al. 2013). Here, we tested whether viruses capa-
ble of escaping UVC-induced mutagenesis can also escape
ribavirin-induced mutagenesis. Specifically, we measured the
inhibition of viral growth caused by ribavirin. Figure 4 shows
that the NE01 and E01 populations became completely resistant
to the effects of ribavirin (P¼ 0.0001 and P¼ 0.0002, respectively)
and yielded equivalent final titers in both the presence and
absence of the drug. Results obtained for control populations
(Rib -) indicate that the observed drug resistance was not due to
the initial cell culture adaptation of E11 in the presence of the
drug (Supplementary Fig. S2), since resistance also emerged in
these control populations.
3.2 Genome evolution
3.2.1 Mutations in the evolved populations
The heatmap in Table 1 shows the SNPs that increased from
minor to major frequency or were fixed in one or more
Ribþpopulations, including the biological replicates. Both syn-
onymous and non-synonymous mutations were fixed in all
virus proteins except 3B. On the contrary, non-synonymous
mutations were observed in the structural proteins VP4 (Y33F),
VP2 (G139R) and VP1 (C236I, M238V, K259Q), and in the non-
structural proteins 2 C (V40A, A61T) and 3Dpol (T347A). The
mutations here identified in the VP4, VP2, and VP1 have been
previously associated with changes in the thermal stability and
alternative receptor use in EV11, respectively (Zhong et al. 2017).
3.2.2 Change in effective population size over time
To characterize the genetic evolution of our adapted viruses at
the population-level, we estimated the overall and time-serial
Ne (Fig. 5; Supplementary Fig. S3). The mode of Ne in the poste-
rior distribution of the E01 is greater than that of the NE01 popu-
lation (835 versus 538, respectively). This increase in diversity
could be induced by the mutagenic effect of UVC in the E01 pop-
ulation. However, given that the number of segregating minor
alleles (above the ascertainment frequency of 0.5%) was smaller
in the E01 than in the NE population (439 versus 624, respec-
tively), a larger census population size in the E01 population is
the more likely explanation. The time-serial Ne in Fig. 5 shows
that the Ne of the E01 population increases more than fourfold
over the course of the experiment, whereas the Ne of the NE01
population remains relatively stable.
Values of Ne estimated protein-by-protein (Supplementary
Fig. S4) also exhibit a difference between the NE01 and E01 pop-
ulations in their responses to serial bottlenecks. To investigate
whether the differences in the Ne estimates of protein-coding
genes was caused by differing selective pressures acting upon
them, we investigated the role of each protein in the genome-
wide response to the experimental evolution regime.
Specifically, we examined pN=pS, a partial indicator of selective
pressure on each protein (i.e. with a ratio equal to one implying
neutrality, and deviations implying the action of positive or
negative selection). Although this ratio is not a monotonic
Figure 4. Viral titre of wild-type (WT), WT Ribþand evolved populations (E01
and NE01) obtained in the stationary growth phase (48–72 hours) in the presence
of ribavirin. Data are presented as the ratio of the titre in the presence versus
absence of the drug. Asterisks indicate a statistically significant difference with
respect to the WT.
Figure 5. Time-serial effective population sizes (Ne) and mutation rate per site
per generation of NE01 (A) and E01 (B) populations. The orange lines indicate the
median of 1000 Ne estimates between consecutive sampling time points with
the given passages. The grey line shows the mutation rate calculated for each
population. The dashed line indicates an increase in the UVC fluence.
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function of the selection coefficient, as it is in the ratio of non-
synonymous to synonymous substitutions (dN=dS) between
species, it can be used as an indicator of selective pressure on
protein-coding genes (Kryazhimskiy and Plotkin 2008). As
shown in Table 2, as expected, all proteins in both the NE01 and
E01 populations appear to be strongly constrained and relaxed
constraint alone thus appears to be a poor explanation for the
observed differences.
3.2.3 Mutation rate estimated from time-series data
The mutation rates of NE01 and E01 estimated from time-series
NGS data in the early passages of our directed evolution experi-
ments (Fig. 5) corresponded to 1.20  107 and 1.40  107 site
per cell infection, respectively). While the trend of the mutation
rate in the NE01 population is more variable over the tested pas-
sages, the mutation rate in this population was consistently
higher than that of the E01 population at each sequenced pas-
sage (Fig. 5), indicating that the E01 population has a higher rep-
lication fidelity than the NE01.
4. Discussion
In this study, we have demonstrated that the efficiency of UVC
is compromised by the emergence of virus populations with
increased resistance to UVC radiation. On the one hand, the
virus populations that were repeatedly exposed to UVC radia-
tion adapted to the stressor with an overall decrease (approxi-
mately 15%) in their sensitivity to UVC. However, the extent of
UVC resistance observed in our work was relatively minor com-
pared to that previously observed for chemical disinfectants
(Bates et al. 1978; Maillard et al. 1998; Zhong et al. 2017). This
implies that despite limited adaptation, UVC remains a useful
tool to control viruses. Nevertheless, adaptation to UVC may be
problematic given the current practices of UV disinfection for
water treatment. For example, the most recognized and cited
UV disinfection guidelines, developed by the German Gas and
Water Association, require that a validated UVC system for
water treatment deliver a fluence of 40 mJ/cm2, with the
assumption that this fluence achieves a 4 log10 inactivation of
pathogens (Wirtschafts und Verlagsgesellschaft Gas und
Wasser 2006). However, this 4 log10 target is not met by popula-
tions with reduced UVC sensitivity, which show an approximate
inactivation of 3.4 log10 at the fluence of 40 mJ/cm
2. The current
guidelines are thus not sufficiently protective for the UVC-
resistant viruses produced herein.
The NGS data did not allow us to identify specific mutations
uniquely responsible for the increased resistance to UVC
(change in k), given that we did not identify any mutation that
was present in all exposed replicates but absent from the non-
exposed ones. However, putatively beneficial mutations were
identified based on observed frequency changes (Table 1),
which are thus candidates for acting epistatically, for underly-
ing what may in fact be a highly polygenic trait, or indeed may
simply represent a wide variety of mutational solutions for
achieving a common phenotype.
Besides increased UVC resistance, an additional phenotypic
trait observed in both non-exposed and UVC-exposed popula-
tions was the sequential onset of biphasic kinetics. This feature
has also been observed in bacterial populations exposed to high
concentrations of antibiotics or heavy metals (Harrison et al.
2005; Lewis 2010; Maisonneuve and Gerdes 2014). These so-
called bacterial persisters may show multi-resistance to diverse
antibiotics by entering a dormancy state and are therefore less
affected by drug treatment. ‘Viral persistence’ as observed
herein cannot be explained by a dormant state, and the molecu-
lar underpinnings of the observed biphasic kinetics are not
understood.
Notably, all the evolved viruses with biphasic inactivation
kinetics also showed resistance to ribavirin, a mutagenic antivi-
ral drug that targets virus replication that is currently used in
clinical therapies (e.g. against hepatitis C virus). Mutations in
the 2 C region of enteroviruses have previously been shown to
confer multi-resistance against ribavirin and other mutagenic
drugs (Baltera and Tershak 1989; Sadeghipour et al. 2012; Agudo
et al. 2016). In addition, poliovirus and human enterovirus 71
with mutations in the 3Dpol coding region were found to exhibit
resistance to ribavirin (Sadeghipour et al. 2013). 2C is a multi-
function protein that is involved in the binding of the polymer-
ase to the nucleic acids and in the exit of virus particles from
the infected cell. 3Dpol is a protein involved in the replication
fidelity of viral polymerase. Here, we identified several muta-
tions in 2 C (V40A, A61T) and 3Dpol (T347A), and these SNPs
were shared by all evolved populations (E and NE). It is thus
likely that these mutations are associated with the novel phe-
notypic characteristics (i.e. the biphasic UVC inactivation
kinetics and the resistance to ribavirin) present in both E and
NE populations.
The onset of biphasic kinetics are of importance for control-
ling the long-term effects of disinfection in clinical settings
where complete sterilization may not be reached and drug
resistant microorganisms may circulate (Moges et al. 2014). In
this context, it is also important to consider that the UV-
tolerant and drug-resistant viruses were capable of outcompet-
ing the wild type in co-cultures of BGMK cells under our experi-
mental conditions. It is not clear that this finding also applies to
human infection by enteroviruses in clinical settings, which
Table 2. The ratio of non-synonymous to synonymous segregating sites (pN=pS) by protein-coding genes accumulated in the NE and E popula-
tions during the experiments.
Protein VP4 VP2 VP3 VP1 2A 2B 2C 3A 3B 3C 3D
Coding
sites
752–958 959–1,744 1745–2,458 2,459–3,334 3,335–3,784 3,785–4,081 4,082–5,068 5,069–5,335 5,336–5,401 5,402–5,950 5,951–7,336
Size 207 786 714 876 450 297 987 267 66 549 1,386
Ribþ NE
pN/pS
0 0.19 0.13 0.36 0.29 0.06 0.16 0.42 0 0.17 0.29
Ribþ E
pN/pS
0.18 0.52 0.28 0.71 0.34 0.37 0.29 0.05 NAa 0.18 0.49
pN/pS values are averages of the four replicates (E01–E04).
aNA, no synonymous segregating sites.
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involves both person-to-person and environmental transmis-
sion (Lu et al. 2015). However, a subset of the mutations identi-
fied herein (Supplementary Table S4) have been previously
described in clinical or environmental isolates of E11, indicating
that these mutations may also be beneficial, or at least not det-
rimental, in the context of overall virus circulation. Notably, the
2C (V40A, A61T) and 3Dpol (T347A) mutations identified in this
study were present in 6 per cent, 26 per cent, and 85 per cent of
the analyzed sequences, respectively.
Viruses with resistance to mutagenic activity have previ-
ously been found to exhibit changes in their replication mecha-
nism, specifically a lowering of their mutation rate (Pfeiffer and
Kirkegaard 2003; Sadeghipour et al. 2013). While we do not have
information on the specific mutation rate of the starting (WT
Ribþ) population, the evolved populations showed a lower
mutation rate than those previously reported for other enterovi-
ruses (e.g. 9  105 substitutions per site per cell infection;
Sanjuan et al. 2010). Furthermore, the mutation rate of the E01
population was consistently lower across all passages com-
pared to the NE01 population. This may be explained by the
interplay of mutation rate and effective population size.
Specifically, during the experimental evolution of NE, samples
were consistently diluted at the start of each passage, resulting
in a constant and low MOI in all passages. This, in turn, yielded
a constant and low Ne across the entire experiment (Fig. 5). In
contrast, the sample size in the E populations were reduced by
UVC at the start of each passage. Thereby the applied UVC flu-
ence was kept constant up to Passage 15 and was only then
increased to correct for the emergence of resistant viruses (Fig.
5). It is possible that the resistance to UVC increased in the early
passages and that consequently the UVC exposure was not suf-
ficient to ensure the same MOI as in the NE populations. This
would lead to a larger census population size in the E popula-
tion and could explain the difference in the Ne values. After
adjusting the UVC fluence at Passage 15, the MOI and hence Ne
decreased. The larger Ne in the early passages of the E popula-
tions may have led to more efficient selection in favor of a lower
mutation rate. The lower mutation rate of E at the nucleotide
level compared to NE is further consistent with its more pro-
nounced phenotypic changes, namely the decrease in the UVC
inactivation constant (k), as well as a higher resistance to
ribavirin.
The benefit of low mutation rates to withstanding UVC or
other mutagenic agents lies in reducing the total mutational
load of the viruses under consideration (Matuszewski et al.
2017). All viruses accumulate similar numbers of mutations
during UVC or ribavirin treatment. In contrast, the number of
additional mutations incurred during viral replication varies
with mutation rate. The total mutational load, and hence also
the number of deleterious mutations, will be lower in those
viruses with a high replication fidelity. Thus, variants with the
highest replication fidelity are thus the most likely to survive
treatment with a mutagenic agents (such as UVC and ribavirin)
followed by regrowth.
In conclusion, our results demonstrate that resistance of
human E11 to UVC may arise and likely exhibits the same
mechanism as previously observed for viruses with resistance
to mutagenic antiviral drugs (i.e. a lowering of the mutation
rate). As such, viruses resistant to UVC may be cross-resistant
to antiviral drugs that act through analogous mechanisms, and
vice versa. Hence, the practice of disinfection, while of course
important, also may contribute to the emergence of multiresist-
ant viruses. These findings are thus relevant for ensuring the
long-term efficiency of UVC radiation in the context of disinfec-
tion in water treatment and in clinical settings.
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